The Oncology Institute, Inc. (TOI) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 5 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for TOI is $5.00, representing a +47.9% upside from the current price of $3.38. Price targets range from a low of $5.00 to a high of $5.00.
